Publication | Open Access

Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings

AngiogenesisMelanomaAdjuvant SettingsImmunologyPotential RoleFibroblast Growth FactorExperimental Metastatic MelanomaNeovascularizationImmunotherapyMedicineRadiation Oncology